ProfileGDS2971 / 5.2.16.19
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 66% 40% 25% 46% 21% 27% 51% 44% 51% 36% 60% 49% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)0.31956966
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.078305240
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.33710325
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-0.03931846
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)-0.4794121
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)-0.40363827
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.044977951
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)-0.088616344
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.064022451
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)-0.19135336
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)0.18150960
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)0.049365649